UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Phase III Randomized Trial of Bisphosphonates as Adjuvant Therapy in Breast Cancer: S0307

JNCI : Journal of the National Cancer Institute, 2020-07, Vol.112 (7), p.698-707

2020

Volltextzugriff (PDF)

Effects of discontinuing oral bisphosphonate treatments for postmenopausal osteoporosis on bone turnover markers and bone density

Osteoporosis international, 2018-06, Vol.29 (6), p.1407-1417

2018

Volltextzugriff (PDF)

Effect of drugs on bone mineral density in postmenopausal osteoporosis: a Bayesian network meta-analysis

Journal of orthopaedic surgery and research, 2021-08, Vol.16 (1), p.533-533, Article 533

2021

Volltextzugriff (PDF)

Computed tomography-based structural rigidity analysis can assess tumor- and treatment-induced changes in rat bones with metastatic lesions

BMC cancer, 2024-06, Vol.24 (1), p.767-13, Article 767

2024

Volltextzugriff (PDF)

Enhancement of Oral Bioavailability of Ibandronate Through Gastroretentive Raft Forming Drug Delivery System: In Vitro and In Vivo Evaluation

International journal of nanomedicine, 2020-01, Vol.15, p.4847-4858

2020

Volltextzugriff (PDF)

Gemcitabine–Ibandronate Conjugate Enables the Bone-Targeted Combination Therapy in Bone Cancer: Synthesis and Efficacy in Combination with Docetaxel

Bioconjugate chemistry, 2021-12, Vol.32 (12), p.2530-2539

2021

Volltextzugriff (PDF)

Comparison of anti-fracture effectiveness of zoledronate, ibandronate and alendronate versus denosumab in a registry-based cohort study

Osteoporosis international, 2023-11, Vol.34 (11), p.1961-1973

2023

Volltextzugriff (PDF)

Effectiveness of monthly intravenous ibandronate on the low responders to oral bisphosphonate: the MOVEMENT study

Journal of bone and mineral metabolism, 2019-11, Vol.37 (6), p.1013-1023

2019

Volltextzugriff (PDF)

Bone-modifying agents for reducing bone loss in women with early and locally advanced breast cancer: a network meta-analysis

Cochrane database of systematic reviews, 2024-07, Vol.7 (7), p.CD013451

2024

Volltextzugriff (PDF)

Inhibition of farnesyl pyrophosphate synthase alleviates cardiomyopathy in diabetic rat

Cell cycle (Georgetown, Tex.), 2023-03, Vol.22 (6), p.666-679

2023

Volltextzugriff (PDF)

Effects of an oral bisphosphonate and three intravenous bisphosphonates on several cell types in vitro

Clinical oral investigations, 2018-09, Vol.22 (7), p.2527-2534

2018

Volltextzugriff (PDF)

Development and application of a urine drug concentration method for the evaluation of oral absorption of ibandronate in clinical patients

Bioanalysis, 2019-07, Vol.11 (14), p.1337-1345

2019

Volltextzugriff (PDF)

Which Bone-Modifying Agent is Associated with Better Outcomes in Patients with Skeletal Metastases from Lung Cancer? A Systematic Review and Network Meta-analysis

Clinical orthopaedics and related research, 2021-09, Vol.479 (9), p.2047-2057

2021

Volltextzugriff (PDF)

Undercarboxylated osteocalcin and ibandronate combination ameliorates hindlimb immobilization‐induced muscle wasting

The Journal of physiology, 2023-05, Vol.601 (10), p.1851-1867

2023

Volltextzugriff (PDF)

The Clinical Effectiveness of Denosumab (Prolia®) for the Treatment of Osteoporosis in Postmenopausal Women, Compared to Bisphosphonates, Selective Estrogen Receptor Modulators (SERM), and Placebo: A Systematic Review and Network Meta-Analysis

Calcified tissue international, 2023-06, Vol.112 (6), p.631-646

2023

Volltextzugriff (PDF)

Ibandronate metal complexes: solution behavior and antiparasitic activity

Journal of biological inorganic chemistry, 2018-03, Vol.23 (2), p.303-312

2018

Volltextzugriff (PDF)

Ibandronate-Loaded Carbon Nanohorns Fabricated Using Calcium Phosphates as Mediators and Their Effects on Macrophages and Osteoclasts

ACS applied materials & interfaces, 2021-01, Vol.13 (3), p.3701-3712

2021

Volltextzugriff (PDF)

Ibandronate Suppresses Changes in Apatite Orientation and Young's Modulus Caused by Estrogen Deficiency in Rat Vertebrae

Calcified tissue international, 2022-06, Vol.110 (6), p.736-745

2022

Volltextzugriff (PDF)

Pharmacological therapies for osteoporosis: a Bayesian network meta-analysis

Medical science monitor, 2022-04, Vol.28, p.e935491-e935491, Article e935491

2022

Volltextzugriff (PDF)

Phase 2 placebo-controlled, single-blind trial to evaluate the impact of oral ibandronate on bone mineral density in osteopenic breast cancer patients receiving adjuvant aromatase inhibitors: 5-year results of the single-centre BONADIUV trial

European journal of cancer (1990), 2019-02, Vol.108, p.100-110

2019

Volltextzugriff (PDF)

Effects of Injected Antiosteoporotic Medication Versus Oral Bisphosphonates on Rates of Repeated Vertebroplasty or Kyphoplasty

Clinical therapeutics, 2020-06, Vol.42 (6), p.1087-1098.e2

2020

Volltextzugriff (PDF)

Racial difference in bioavailability of oral ibandronate between Caucasian and Taiwanese postmenopausal women

Osteoporosis international, 2020, Vol.31 (1), p.193-201

2020

Volltextzugriff (PDF)

Efficacy of bisphosphonate therapy on postmenopausal osteoporotic women with and without diabetes: a prospective trial

BMC endocrine disorders, 2022-04, Vol.22 (1), p.99-99, Article 99

2022

Volltextzugriff (PDF)

Erythema multiforme caused by ibandronate sodium: A rare case report

Dermatologic therapy, 2019-07, Vol.32 (4), p.e12984-n/a

2019

Volltextzugriff (PDF)

Does Local Ibandronate and/or Pamidronate Delivery Enhance Osseointegration? A Systematic Review

Journal of prosthodontics, 2018-03, Vol.27 (3), p.240-249

2018

Volltextzugriff (PDF)

1 – 25 von 315

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(306)
Mit Volltextzugriff
(271)

Publikationsform

Artikel
(315)

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Ibandronic Acid
(285)
Science & Technology
(257)
Life Sciences & Biomedicine
(241)
Humans
(199)
Bisphosphonates
(179)
Female
(150)
Osteoporosis
(133)
Diphosphonates - Therapeutic Use
(104)
Diphosphonates - Administration & Dosage
(90)
Zoledronic Acid
(90)
Middle Aged
(86)
Aged
(77)
Bone Density Conservation Agents - Therapeutic Use
(72)
Ibandronate
(68)
Endocrinology & Metabolism
(66)
Fractures
(65)
Alendronic Acid
(62)
Risedronic Acid
(61)
Male
(58)
Biological And Medical Sciences
(56)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Phase III Randomized Trial of Bisphosphonates as Adjuvant Therapy in Breast Cancer: S0307

Effects of discontinuing oral bisphosphonate treatments for postmenopausal osteoporosis on bone turnover markers and bone density

Effect of drugs on bone mineral density in postmenopausal osteoporosis: a Bayesian network meta-analysis

Computed tomography-based structural rigidity analysis can assess tumor- and treatment-induced changes in rat bones with metastatic lesions

Enhancement of Oral Bioavailability of Ibandronate Through Gastroretentive Raft Forming Drug Delivery System: In Vitro and In Vivo Evaluation

Gemcitabine–Ibandronate Conjugate Enables the Bone-Targeted Combination Therapy in Bone Cancer: Synthesis and Efficacy in Combination with Docetaxel

Comparison of anti-fracture effectiveness of zoledronate, ibandronate and alendronate versus denosumab in a registry-based cohort study

Effectiveness of monthly intravenous ibandronate on the low responders to oral bisphosphonate: the MOVEMENT study

Bone-modifying agents for reducing bone loss in women with early and locally advanced breast cancer: a network meta-analysis

Inhibition of farnesyl pyrophosphate synthase alleviates cardiomyopathy in diabetic rat

Effects of an oral bisphosphonate and three intravenous bisphosphonates on several cell types in vitro

Development and application of a urine drug concentration method for the evaluation of oral absorption of ibandronate in clinical patients

Which Bone-Modifying Agent is Associated with Better Outcomes in Patients with Skeletal Metastases from Lung Cancer? A Systematic Review and Network Meta-analysis

Undercarboxylated osteocalcin and ibandronate combination ameliorates hindlimb immobilization‐induced muscle wasting

The Clinical Effectiveness of Denosumab (Prolia®) for the Treatment of Osteoporosis in Postmenopausal Women, Compared to Bisphosphonates, Selective Estrogen Receptor Modulators (SERM), and Placebo: A Systematic Review and Network Meta-Analysis

Ibandronate metal complexes: solution behavior and antiparasitic activity

Ibandronate-Loaded Carbon Nanohorns Fabricated Using Calcium Phosphates as Mediators and Their Effects on Macrophages and Osteoclasts

Ibandronate Suppresses Changes in Apatite Orientation and Young's Modulus Caused by Estrogen Deficiency in Rat Vertebrae

Pharmacological therapies for osteoporosis: a Bayesian network meta-analysis

Phase 2 placebo-controlled, single-blind trial to evaluate the impact of oral ibandronate on bone mineral density in osteopenic breast cancer patients receiving adjuvant aromatase inhibitors: 5-year results of the single-centre BONADIUV trial

Effects of Injected Antiosteoporotic Medication Versus Oral Bisphosphonates on Rates of Repeated Vertebroplasty or Kyphoplasty

Racial difference in bioavailability of oral ibandronate between Caucasian and Taiwanese postmenopausal women

Efficacy of bisphosphonate therapy on postmenopausal osteoporotic women with and without diabetes: a prospective trial

Erythema multiforme caused by ibandronate sodium: A rare case report

Does Local Ibandronate and/or Pamidronate Delivery Enhance Osseointegration? A Systematic Review

Suchergebnisse filtern